BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31308693)

  • 1. LSD1 regulates Notch and PI3K/Akt/mTOR pathways through binding the promoter regions of Notch target genes in esophageal squamous cell carcinoma.
    Hou G; Zhao Q; Zhang M; Wang P; Ye H; Wang Y; Ren Y; Zhang J; Lu Z
    Onco Targets Ther; 2019; 12():5215-5225. PubMed ID: 31308693
    [No Abstract]   [Full Text] [Related]  

  • 2. FLI-06 suppresses proliferation, induces apoptosis and cell cycle arrest by targeting LSD1 and Notch pathway in esophageal squamous cell carcinoma cells.
    Lu Z; Ren Y; Zhang M; Fan T; Wang Y; Zhao Q; Liu HM; Zhao W; Hou G
    Biomed Pharmacother; 2018 Nov; 107():1370-1376. PubMed ID: 30257352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy.
    Luo Q; Du R; Liu W; Huang G; Dong Z; Li X
    Front Oncol; 2022; 12():852383. PubMed ID: 35392233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing UHRF1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Inhibiting the PI3K/Akt/mTOR Signaling Pathway.
    Hui B; Pan S; Che S; Sun Y; Yan Y; Guo J; Gong T; Ren J; Zhang X
    Cancer Manag Res; 2021; 13():4841-4852. PubMed ID: 34188537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. shRNA-interfering LSD1 inhibits proliferation and invasion of gastric cancer cells
    Pan HM; Lang WY; Yao LJ; Wang Y; Li XL
    World J Gastrointest Oncol; 2019 Aug; 11(8):622-633. PubMed ID: 31435463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
    Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
    Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
    Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
    Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma.
    Huang R; Dai Q; Yang R; Duan Y; Zhao Q; Haybaeck J; Yang Z
    Front Oncol; 2022; 12():817916. PubMed ID: 35574327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.
    Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo.
    Xi R; Pan S; Chen X; Hui B; Zhang L; Fu S; Li X; Zhang X; Gong T; Guo J; Zhang X; Che S
    Oncotarget; 2016 Aug; 7(35):57050-57065. PubMed ID: 27489353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of lysine-specific demethylase 1 correlates with poor prognosis of patients with esophageal squamous cell carcinoma.
    Yu Y; Wang B; Zhang K; Lei Z; Guo Y; Xiao H; Wang J; Fan L; Lan C; Wei Y; Ma Q; Lin L; Mao C; Yang X; Chen X; Li Y; Bai Y; Chen D
    Biochem Biophys Res Commun; 2013 Jul; 437(2):192-8. PubMed ID: 23747727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.
    Li F; Zhang Z; Wang P; Wen P; Xu Q; Wang Y; Pan P; Ma L
    Life Sci; 2019 Sep; 232():116679. PubMed ID: 31340168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
    Zhang J; Liu S; Zhang D; Ma Z; Sun L
    J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway.
    Ma S; Liu T; Xu L; Wang Y; Zhou J; Huang T; Li P; Liu H; Zhang Y; Zhou X; Cui Y; Zang X; Wang Y; Guan F
    J Cell Physiol; 2019 Dec; 234(12):22400-22410. PubMed ID: 31120582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.
    Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM
    Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RICTOR/mTORC2 affects tumorigenesis and therapeutic efficacy of mTOR inhibitors in esophageal squamous cell carcinoma.
    Lu Z; Shi X; Gong F; Li S; Wang Y; Ren Y; Zhang M; Yu B; Li Y; Zhao W; Zhang J; Hou G
    Acta Pharm Sin B; 2020 Jun; 10(6):1004-1019. PubMed ID: 32642408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma.
    Piao L; Yang Z; Jin J; Ni W; Qi W; Xuan Y
    Hum Pathol; 2018 Oct; 80():152-162. PubMed ID: 29885401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway.
    Shen Z; Xu L; Li J; Zhang N
    Med Sci Monit; 2017 May; 23():2096-2103. PubMed ID: 28463955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-18a promotes cell proliferation of esophageal squamous cell carcinoma cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR signaling axis.
    Zhang W; Lei C; Fan J; Wang J
    Biochem Biophys Res Commun; 2016 Aug; 477(1):144-149. PubMed ID: 27291152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LSD1 Activates PI3K/AKT Signaling Through Regulating p85 Expression in Prostate Cancer Cells.
    Wang Z; Gao S; Han D; Han W; Li M; Cai C
    Front Oncol; 2019; 9():721. PubMed ID: 31428587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.